NCT05206656 2022-11-23Safety and Efficacy of Eribullin or Eribulin Combined With Anlotinib in Metastatic Breast CancerHunan Cancer HospitalPhase 2 Completed80 enrolled
NCT04002284 2020-07-29Anlotinib in Metastatic HER2 Negative Breast CancerChineseAMSPhase 2 Completed26 enrolled